Decreased Clearance of CNS β-Amyloid in Alzheimer's Disease

摘要:

Alzheimer's disease is hypothesized to be caused by an imbalance between β-amyloid (Aβ) production and clearance that leads to Aβ accumulation in the central nervous system (CNS). Aβ production and clearance are key targets in the development of disease-modifying therapeutic agents for Alzheimer's disease. However, there has not been direct evidence of altered Aβ production or clearance in Alzheimer's disease. By using metabolic labeling, we measured Aβ42 and Aβ40 production and clearance rates in the CNS of participants with Alzheimer's disease and cognitively normal controls. Clearance rates for both Aβ42 and Aβ40 were impaired in Alzheimer's disease compared with controls. On average, there were no differences in Aβ40 or Aβ42 production rates. Thus, the common late-onset form of Alzheimer's disease is characterized by an overall impairment in Aβ clearance.

展开

DOI:

10.1126/science.1197623

被引量:

2855

年份:

2010

相似文献

参考文献

引证文献

来源期刊

引用走势

2014
被引量:454

辅助模式

0

引用

文献可以批量引用啦~
欢迎点我试用!

引用